{"id":132322,"date":"2021-07-15T15:22:42","date_gmt":"2021-07-15T15:22:42","guid":{"rendered":"https:\/\/precoinnews.com\/?p=132322"},"modified":"2021-07-15T15:22:42","modified_gmt":"2021-07-15T15:22:42","slug":"nls-pharmaceutics-jumps-4-on-getting-fda-acceptance-for-its-quilience-ind","status":"publish","type":"post","link":"https:\/\/precoinnews.com\/bitcoin\/nls-pharmaceutics-jumps-4-on-getting-fda-acceptance-for-its-quilience-ind\/","title":{"rendered":"NLS Pharmaceutics Jumps 4% On Getting FDA Acceptance For Its Quilience IND"},"content":{"rendered":"
Shares of Swiss clinical-stage pharmaceutical company NLS Pharmaceutics AG (NLSP) are climbing more than 4% Thursday morning.<\/p>\n
NLS today said, the FDA has accepted its investigational new drug application (IND) for Quilience, the Company’s lead drug candidate, for the treatment of narcolepsy.<\/p>\n
The company plans to start Phase 2a study of Quilience in August 2021.<\/p>\n
NLSP is at $3.13 currently. It has traded in the range of $2.06- $7.35 in the last one year. <\/p>\n